Alnylam Pharmaceuticals
ALNY
#650
Rank
ยฃ29.42 B
Marketcap
ยฃ220.42
Share price
-0.61%
Change (1 day)
-7.26%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company